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Abstract
Pyruvate dehydrogenase kinases (PDK1-4) play a critical role in the inhibition of the mitochondrial pyruvate dehydrogenase
complex especially when blood glucose levels are low and pyruvate can be conserved for gluconeogenesis. Under diabetic
conditions, the Pdk genes, particularly Pdk4, are often induced, and the elevation of the Pdk4 gene expression has been
implicated in the increased gluconeogenesis in the liver and the decreased glucose utilization in the peripheral tissues.
However, there is no direct evidence yet to show to what extent that the dysregulation of hepatic Pdk genes attributes to
hyperglycemia and insulin resistance in vivo. To address this question, we crossed Pdk2 or Pdk4 null mice with a diabetic
model that is deficient in hepatic insulin receptor substrates 1 and 2 (Irs1/2). Metabolic analyses reveal that deletion of the
Pdk4 gene had better improvement in hyperglycemia and glucose tolerance than knockout of the Pdk2 gene whereas the
Pdk2 gene deletion showed better insulin tolerance as compared to the Pdk4 gene inactivation on the Irs1/2 knockout
genetic background. To examine the specific hepatic effects of Pdks on diabetes, we also knocked down the Pdk2 or Pdk4
gene using specific shRNAs. The data also indicate that the Pdk4 gene knockdown led to better glucose tolerance than the
Pdk2 gene knockdown. In conclusion, our data suggest that hepatic Pdk4 may be critically involved in the pathogenesis of
diabetes.
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Introduction
Mitochondrial pyruvate dehydrogenase complex (PDC) plays
an essential role in glucose metabolism by converting pyruvate
to acetyl-CoA in glycolysis [1]. The activity of PDC is not only
allosterically regulated by acetyl-CoA and NADH, but also by
covalent modifications such as phosphorylation that is con-
trolled by four pyruvate dehydrogenase kinases (Pdks) and two
pyruvate dehydrogenase phosphatases (Pdps) [1]. Pdks have
differential tissue distribution: Pdk1 is abundant in the heart and
is expressed at a low level in other organs; Pdk2 is ubiquitously
expressed in most tissues; Pdk3 is abundant in testis and is
expressed at a low level in other organs; Pdk4 is highly
expressed in the heart and skeletal muscle and is also expressed
at an intermediate level in the liver, lung, and kidney [2–6].
Among these Pdks, Pdk4 is highly inducible by starvation and it
is also elevated under insulin resistance [6–15]. Systemic Pdk4
knockout leads to hypoglycemia after the prolonged starvation
[16]. In contrast, Pdk2 null mice only manifest a moderate
reduction in blood glucose under non-fasted conditions [17].
When challenged by a high-fat diet, Pdk4 knockout mice exhibit
lower blood glucose levels and better glucose tolerance relative
to the control wild-type mice [18].
The Pdk4 gene expression can be suppressed by insulin under
normal physiological conditions [10]. Insulin receptor substrates
(Irs) play an essential role in the insulin signal transduction through
a direct mediation of insulin receptor activities [19]. There are
four Irs genes in mammals, and among them, Irs1 and Irs2 are
ubiquitously expressed. Mouse genetic data have shown that
deletion of Irs1 and Irs2 genes in the mouse liver (IrsLDKO) causes
severe insulin resistance and early onset of diabetes [20,21]. It is
also noticed that Pdk4 gene expression is highly induced in the liver
of the IrsLDKO mice due to the impairment of insulin signaling
[20]; however, it is not clear that, to what extent, the elevated
Pdk4 contributes to the diabetes in the IrsLDKO mice. To address
this question, we genetically inactivated Pdk2 or Pdk4 in the
IrsLDKO mice. Our results indicate that Pdk4 indeed plays a
more significant role in the development of hyperglycemia and
glucose intolerance in this hepatic insulin resistance model.
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Materials and Methods
Animals
Irs1 and Irs2 floxed mice and Pdk2/4 null mice were generated
as previously described [16,17,20]. Transgenic mice that carry a
Cre coding sequence plus the Albumin gene promoter were
purchased from the Jackson Laboratory. For insulin stimulation,
animals were anesthetized before a bolus of 5 units of insulin
(human regular insulin — humulin R, Eli Lilly) was injected via
vena cava for 3 min.
Ethics statement
All procedures were performed in accordance with the Guide
for Care and Use of Laboratory Animals of the National Institutes
of Health and were approved by the Institutional Animal Use and
Care Committee of Indiana University School of Medicine (study
10322).
Blood chemistry and metabolic analysis
Blood glucose levels were measured using a glucose meter under
ad libitum (fed) or overnight 16-hour fasting. Serum insulin was
measured using commercial assay kits (ALPCO). Glucose and
Figure 1. Knockout of the Pdk genes in wild-type and IrsLDKO mice. A, Control wild-type and IrsLDKO mice (n = 3) were fasted overnight for
16 hours and half of them were fed for 4 hours immediately after the fasting. Pdks gene expression in the liver was analyzed by real-time PCR and
data were normalized to an internal control gene — Ppia. B, Western blot analysis of liver lysates from control and knockout mice. C, Body weight
measurements in control and knockout mice (n = 6–20). D, Serum triglycerides (TG) were measured in overnight fasted control and knockout mice
(n = 6–8). E, Liver TG analysis in control and knockout mice (n = 6–8). Pdk2KO, Pdk2 knockout; Pdk4KO, Pdk4 knockout; IrsLDKO, Irs1/2 liver-specific
double knockout. Data are presented as means 6 SEM. *, P,0.05 relative to corresponding controls.
doi:10.1371/journal.pone.0071997.g001
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insulin tolerance tests were performed as previously described
[22], and 2 g glucose and 1 unit human regular insulin per kg
body weight were used, respectively.
Immunoblot analysis
Liver tissue was homogenized in the lysis buffer (50 mM Hepes,
pH 7.5, 150 mM NaCl, 10% Glycerol, 1% Triton X-100,
1.5 mM MgCl2, 1 mM EGTA, 10 mM Sodium Pyrophosphate,
100 mM Sodium Fluoride and freshly added 100 uM Sodium
Vanadate, 1 mM PMSF, 10 ug/ml Aprotinin, and 10 ug/ml
Leupeptin). Protein extracts were resolved on an SDS-PAGE gel
and transferred to nitrocellulose membrane. Proteins were probed
using the following antibodies: Irs1 and Irs2 (Millipore), Pdk2,
Pdk4, b-actin and Actinin (Santa Cruz Biotechnology), total and
phosphorylated Akt and Erk (Cell Signaling Technology). Protein
signals were detected by incubation with HRP-conjugated
secondary antibodies, followed by ECL detection reagent (Thermo
Fisher Scientific Inc.).
Adenovirus-mediated gene knockdown in vivo
Gene-specific shRNAs were designed using the BLOCK-iT
RNAi Designer (Invitrogen) and cloned using a BLOCK-iT
system (Invitrogen). The target template sequences are the
followings: shGFP, 59-GCATCAAGGTGAACTTCAAGA-39;
shPdk2, 59-GGCTCTTCAGCTACATGTACT-39; and shPdk4,
59-GGAAGGAATCAAAGCACTTTA-39. Adenoviruses were
prepared following the standard procedure. Mice were injected
with adenoviruses (16109 pfu/animal) via tail vein as previously
described [23]. Three days post-injection, glucose tolerance tests
were performed. Five days post-injection, insulin tolerance tests
were performed. On day 7 post-injection, animals were fasted
overnight for 16 hours before tissues were collected for further
analysis.
Real-time PCR
Liver RNA isolation was performed as previously described (6).
Quantitative RT-PCR (RT-qPCR) was performed in two steps:
first, cDNA was synthesized using a cDNA synthesis kit (Applied
Biosystems Inc.); second, cDNA was analyzed by real-time PCR
Figure 2. Deletion of the Pdk4 gene improves hyperglycemia in
IrsLDKO mice. A, Blood glucose was measured in overnight fasted
control and knockout mice. B, Blood glucose was measured in ad
libitum fed control and knockout mice. Data are presented as means 6
SEM, n = 8–23. *, P,0.05 relative to corresponding controls.
doi:10.1371/journal.pone.0071997.g002
Figure 3. Ablation of Pdks improves glucose tolerance in
IrsLDKO mice. A, Glucose tolerance tests (GTT) were performed in
age-matched control and knockout mice (n = 8–12). B and C, Expression
of gluconeogenic genes Pck1 and G6pc was analyzed in the liver of
overnight fasted control and knockout mice (n = 3). Data are presented
as means 6 SEM. *, P,0.05 relative to corresponding controls.
doi:10.1371/journal.pone.0071997.g003
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using SYBR Green Master Mix (Promega). Primer sequences for
the specific genes are as follows: Ppia forward 59-CACCG-
TGTTCTTCGACATCA-39; Ppia reverse 59-CAGTGCTCA-
GAGCTCGAAAGT-39; Pdk2 forward 59- TGGAAAGCTCC-
GAGTTCAGT; Pdk2 reverse 59- GGAGACTGGCACTCAC-
CACT-39; Pdk4 forward 59- GATTGACATCCTGCCTGACC-
39; Pdk4 reverse 59- CATGGAACTCCACCAAATCC-39; Pck1
forward ATCATCTTTGGTGGCCGTAG; Pck1 reverse
TGATGATCTTGCCCTTGTGT; G6pc forward TCGGA-
GACTGGTTCAACCTC; G6pc reverse TCACAGGTGA-
CAGGGAACTG.
Statistics
Data are presented as means 6 SEM. Student’s t-test (2-way)
was performed to test significance between two groups. P,0.05
was considered as a statistical significance.
Results
Inactivation of Pdk2 or Pdk4 improves glucose
homeostasis in IrsLDKO mice
It has been previously reported that hepatic Irs1 and Irs2 play a
crucial role in glucose homeostasis because simultaneous deletions
of both genes in the liver (IrsLDKO) lead to diabetes in mice
[20,21]. Since Pdks can promote hepatic gluconeogenesis, it is
possible that they contribute to the development of hyperglycemia
in the IrsLDKO mice. To test this hypothesis, we first analyzed
expression of all four Pdk genes in the liver of control wild-type
and IrsLDKO mice after an overnight 16-hour fasting or
immediately followed by 4-hour refeeding. According to mRNA
analysis, Pdk2 is the most abundant among four Pdks in the liver
of wild-type mice whereas Pdk4 was induced most in the fasted
IrsLDKO livers (Figure 1A). Interestingly, refeeding could still
suppress the hepatic Pdk4 gene expression in the IrsLDKO mice
(Figure 1A). To further investigate the role of Pdk2 and Pdk4 in
the pathogenesis of diabetes in the IrsLDKO mice, we deleted
either the Pdk2 or Pdk4 gene on the IrsLDKO genetic
background (Figure 1B). While Pdk4 knockout mice were
significantly smaller than control wild-type mice, Pdk4 deletion
had no effect on the body weight of growth-retarded IrsLDKO
mice (Figure 1C). Neither Pdk2 nor Pdk4 deletion had any
significant effect on serum or hepatic triglycerides in the
IrsLDKO mice (Figure 1, D and E). We then monitored blood
glucose levels in control wild-type, single, double, and triple
knockout mice. Deletion of Pdk2 or Pdk4 on the IrsLDKO
genetic background (IrsLDKO:Pdk2KO and IrsLD-
KO:Pdk4KO, respectively) significantly lowered blood glucose
levels under the fasting conditions (Figure 2A). In contrast, only
IrsLDKO:Pdk4KO mice showed a significant decrease in blood
glucose levels under the non-fasting conditions (Figure 2B).
Additionally, deletion of either Pdk2 or Pdk4 also improved
glucose metabolism during glucose tolerance tests, but ablation
of the Pdk4 gene had a more significant effect (Figure 3A). Gene
expression analysis also revealed a significant decrease in Pck1
(phosphoenoylpyruvate carboxykinase 1) but not G6pc (glucose-
6-phosphatase, catalytic) mRNAs, suggesting that hepatic
gluconeogenesis might be reduced in the IrsLDKO:Pdk4KO
mice (Figure 3, B and C).
Deletion of Pdk2 or Pdk4 improves insulin resistance in
IrsLDKO mice
To examine whether Pdk2 or Pdk4 knockout might affect insulin
resistance in IrsLDKO mice, we performed insulin tolerance tests.
The data showed that either Pdk2 or Pdk4 gene deletion
remarkably improved insulin tolerance in the IrsLDKO mice
(Figure 4A). In addition, fasting plasma insulin levels were also
significantly reduced in IrsLDKO:Pdk2KO and IrsLD-
KO:Pdk4KO mice (Figure 4B). The HOMA-IR (homeostatic
model analysis-insulin resistance) analysis indicated improved
insulin resistance in those triple knockout mice (Figure 4C). In
order to understand molecular changes during insulin action, we
also analyzed insulin signaling in the liver and skeletal muscle. Akt
phosphorylation (Ser473) was moderately elevated in the liver of
Figure 4. Inactivation of Pdks improves insulin sensitivity in
IrsLDKO mice. A, Insulin tolerance tests (ITT) were performed in age-
matched control and knockout mice (n = 8–20). B, Fasting plasma
insulin was analyzed in age-matched control and knockout mice (n = 5–
9). C, HOMA-IR (homeostatic model assessment-insulin resistance) was
analyzed using fasting glucose and insulin data. Data are presented as
means 6 SEM. *, P,0.05 relative to corresponding controls.
doi:10.1371/journal.pone.0071997.g004
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IrsLDKO:Pdk2KO and IrsLDKO:Pdk4KO mice, and Erk1/2
phosphorylation (Thr202/Tyr204) was not significantly changed
in the IrsLDKO:Pdk4KO or IrsLDKO:Pdk2 livers as compared
to IrsLDKO livers (Figure 5A). No significant changes in insulin
signaling were observed in the skeletal muscle of IrsLD-
KO:Pdk2KO or IrsLDKO:Pdk4KO mice in comparison to
IrsLDKO mice (Figure 5B).
Liver-specific knockdown of Pdk2 or Pdk4 in IrsLDKO
mice
In order to directly assess the role of hepatic Pdks in glucose
homeostasis, we used adenovirus-mediated shRNAs to knock
down Pdk2 or Pdk4 specifically in the liver. Pdk2 and Pdk4 mRNA
levels were reduced 85% and 60%, respectively (Figure 6A).
Interestingly, although the Pdk4 knockdown efficiency was less
than that of Pdk2, glucose tolerance was improved only in the
Pdk4 knockdown mice in the last two time points during the
glucose tolerance tests and the area under curve was significantly
decreased in the Pdk4 knockdown group (Figure 6, B and C).
Insulin tolerance tests did not reveal a significant improvement in
either Pdk2 or Pdk4 knockdown mice although Pdk4 knockdown
had a trend of improvement of insulin resistance (Figure 7, A and
B). Insulin signaling analysis did not reveal any significant
improvement in Akt phosphorylation in the liver or skeletal
Figure 5. Insulin signaling analysis in the control and knockout mice. A and B, Animals were stimulated with 5 units of human insulin (saline
as a vehicle control) for 3 min before liver and skeletal muscle samples were collected for Akt and Erk phosphorylation analyses. Western blot signals
were quantified using the Quantity One software (Bio-Rad). Data are presented as means 6 SEM. *, P,0.05 relative to corresponding controls.
doi:10.1371/journal.pone.0071997.g005
Role of Pdk2/4 in Diabetes
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muscle of shPdk2 or shPdk4 mice as compared to shGFP control
mice (Figure 7, C–F).
Discussion
In this study, we directly assessed the involvement of Pdk2 and
Pdk4 in the pathogenesis of diabetes. As Pdks regulate glucose
homeostasis at least in two ways — inhibiting glycolysis and
promoting gluconeogenesis, deletion of Pdk genes is expected
to improve hyperglycemia and glucose tolerance. Indeed,
both Pdk2 and Pdk4 ablations can improve glucose tolerance
in the IrsLDKO mice, but only the Pdk4 gene inactivation
lowers both fasting and non-fasting glucose levels whereas
the Pdk2 gene deletion only decreases fasting blood glucose.
This is quite intriguing because both Pdk2 and Pdk4 genes
are ubiquitously expressed in most tissues and Pdk2 has been
shown to be more potent for the inhibition of the PDC
activity [3,4,17]. However, Pdk2 has also been shown to be
more sensitive than other Pdks in response to allosteric
regulators like pyruvate, NADH, and acetyl-CoA [24,25].
Under non-diabetic conditions, Pdk2 deficiency causes a
modest decrease in fed glucose levels whereas Pdk4
deficiency results in lower fasting glucose levels in mice as
compared to the wild-type controls [17]. The differential
effects can also be attributable to their respective modulation
of the PDC activity since Pdk2 deficiency leads to increased
PDC activity only in a fed state and Pdk4 deficiency affects
the PDC activity in both fed and fasting states [17]. It seems
that Pdk2 mainly regulates glucose utilization whereas Pdk4
may be involved in both hepatic gluconeogenesis and
systemic glucose metabolism. In diabetic IrsLDKO mice
that have severe hepatic insulin resistance, although glucose
disposal may be decreased, the unsuppressed hepatic glucose
production may be the major cause of hyperglycemia [26].
Under this condition, inactivation of the Pdk4 gene produces
a better effect than that by the Pdk2 gene deletion largely
because of a stronger role of Pdk4 in hepatic gluconeogen-
esis. This interpretation is supported by our data of the
better glucose tolerance in the IrsLDKO:Pdk4 mice and the
better insulin-stimulated glucose metabolism in the IrsLD-
KO:Pdk2 mice.
Although IrsLDKO mice are only deficient in hepatic Irs1
and Irs2, they manifest systemic insulin resistance as well
[20,21], which is indicated by decreased phosphorylation of
Akt and Erk in the skeletal muscle (Figure 5B). In addition to
the liver, the role of Pdks in other tissues including skeletal
muscle and fat may be also critical for glucose homeostasis.
This interpretation is consistent with our liver-specific
knockdown of the Pdk4 gene since the Pdk4 knockdown only
results in moderate changes in glucose tolerance in the
IrsLDKO mice. But we should caution not to over-interpret
the data due to the less ideal knockdown efficiency for the
Pdk4 gene.
The importance of Pdk4 in metabolism is evidenced by its
dynamic gene expression in response to numerous factors,
including insulin, glucocorticoid, fatty acids, bile acids, thyroid
hormone, angiotensin II, retinoic acids, prolactin, growth
hormone, adiponectin, epinephrine, thiazolidinediones, fibrates,
statins, metformin, and others [7,8,13,14,22,27–40]. Moreover,
Pdk4 gene expression is often induced in the liver and skeletal
muscle under insulin resistance and diabetes conditions [6–15].
From this and other gene knockout studies [17,18,41,42], it
seems likely that a selective inhibition of the Pdk4 activity may
be useful to normalize glucose metabolism and improve insulin
resistance.
In summary, hepatic Pdk4 gene expression is highly induced in
diabetes. Inactivation of the Pdk4 gene can improve hyperglyce-
mia, glucose tolerance, and insulin resistance in diabetic mice.
Overall, our data suggest that Pdk4 may be a useful therapeutic
target for type 2 diabetes.
Figure 6. Hepatic Pdk4 knockdown moderately improves
glucose tolerance in IrsLDKO mice. A, Gene knockdown efficiency
was analyzed by real-time PCR in IrsLDKO livers transduced with shRNA
adenoviruses against GFP (shGFP), Pdk2 (shPdk2), or Pdk4 (shPdk4). B,
Glucose tolerance tests were performed in shRNA adenoviruses infected
IrsLDKO mice. C, Area under curve analysis (AUC) was performed for the
above glucose tolerance test data. Data are presented as means6 SEM,
n = 4–5. *, P,0.05 relative to corresponding controls.
doi:10.1371/journal.pone.0071997.g006
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